Early metabolic response assessment to neoadjuvant endocrine treatment in ER+, HER2- breast cancer: comparison to the morphological and pathological response.

Sarah Boughdad; laurence champion; Veronique Becette; Pascal Cherel; Emmanuelle Mouret-Fourme; Veronique Edeline; Jerome Lemonnier; Florence Lerebours; Jean-Louis Alberini

Meeting ReportOncology: Clinical Diagnosis

Early metabolic response assessment to neoadjuvant endocrine treatment in ER+, HER2- breast cancer: comparison to the morphological and pathological response.

Sarah Boughdad, laurence champion, Veronique Becette, Pascal Cherel, Emmanuelle Mouret-Fourme, Veronique Edeline, Jerome Lemonnier, Florence Lerebours and Jean-Louis Alberini

Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1311;

Sarah Boughdad

1Nuclear Medicine, Insitut Curie-Centre René Huguenin, Saint-Cloud, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

laurence champion

1Nuclear Medicine, Insitut Curie-Centre René Huguenin, Saint-Cloud, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Veronique Becette

2Institut Curie-Centre René Huguenin, Saint-Cloud, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pascal Cherel

2Institut Curie-Centre René Huguenin, Saint-Cloud, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Emmanuelle Mouret-Fourme

2Institut Curie-Centre René Huguenin, Saint-Cloud, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Veronique Edeline

1Nuclear Medicine, Insitut Curie-Centre René Huguenin, Saint-Cloud, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jerome Lemonnier

3Unicancer, Paris, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Florence Lerebours

2Institut Curie-Centre René Huguenin, Saint-Cloud, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jean-Louis Alberini

1Nuclear Medicine, Insitut Curie-Centre René Huguenin, Saint-Cloud, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics

Article Figures & Data

Figures

Download figure
Open in new tab
Download powerpoint

In this issue

Journal of Nuclear Medicine

Vol. 56, Issue supplement 3

May 1, 2015

Table of Contents
Index by author

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Early metabolic response assessment to neoadjuvant endocrine treatment in ER+, HER2- breast cancer: comparison to the morphological and pathological response.

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Early metabolic response assessment to neoadjuvant endocrine treatment in ER+, HER2- breast cancer: comparison to the morphological and pathological response.

Sarah Boughdad, laurence champion, Veronique Becette, Pascal Cherel, Emmanuelle Mouret-Fourme, Veronique Edeline, Jerome Lemonnier, Florence Lerebours, Jean-Louis Alberini

Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1311;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Early metabolic response assessment to neoadjuvant endocrine treatment in ER+, HER2- breast cancer: comparison to the morphological and pathological response.

Sarah Boughdad, laurence champion, Veronique Becette, Pascal Cherel, Emmanuelle Mouret-Fourme, Veronique Edeline, Jerome Lemonnier, Florence Lerebours, Jean-Louis Alberini

Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1311;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Info & Metrics

No related articles found.

Google Scholar

Cited By...

No citing articles found.

Google Scholar

Oncology: Clinical Diagnosis

Is childhood obesity linked to lymphoma?
Imaging characteristics of ¹⁸F-FDG PET/CT in patients with newly diagnosed angio-immunoblastic T cell lymphoma
Changes and reproducibility of uptake in renal medulla on ¹⁸F-FDG PET/CT between before and after diuretics

Show more Oncology: Clinical Diagnosis

MTA I: Breast Cancer Posters

Comparison of diagnostic performance of dbPET and WB-PET/CT in detection of breast cancer according to histological grade/histopathological classification
FDG PET/CT & Breast Cancer: Value of Fourth and Subsequent Post Therapy follow up scans for Patient Management
Background 18F-FDG uptake in positron emission mammography (PEM): the alteration by menstrual cycle

Show more MTA I: Breast Cancer Posters

Main menu

User menu

Search

Early metabolic response assessment to neoadjuvant endocrine treatment in ER+, HER2- breast cancer: comparison to the morphological and pathological response.

Article Figures & Data

Figures

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Oncology: Clinical Diagnosis

MTA I: Breast Cancer Posters

Similar Articles